Academic Staff

Assoc. Prof. Surakit Nathisuwan Assoc. Prof. Surakit Nathisuwan surakit.nat@mahidol.ac.th surakit.nat@mahidol.ac.th Department of Pharmacy, Faculty of Pharmacy, Mahidol University.

2021

1. Educational program to improve hypertension knowledge by a community pharmacist in a rural district in Indonesia

   Wulandari UA, Kristina SA, Chindavijak B, Chulavatnatol S, Nathisuwan S*. JACCP journal of the american college of clinical pharmacy 2021; 4(6): 711-717.
   
   

2. Effect of tomato, lycopene and related products on blood pressure: A systematic review and network meta-analysis

   Rattanavipanon W, Nithiphongwarakul C, Sirisuwansith P, Chaiyasothi T, Thakkinstian A, Nathisuwan S, Pathomwichaiwat T*. Phytomedicine 2021; 88: 153512.
   
   

3. Effects of pharmacist interventions on heart failure outcomes: A systematic review and meta-analysis

   Arunmanakul P, Kengkla K, Chaiyasothi T, Phrommintikul A, Ruengorn C, Permsuwan U, Thakkinstian A, Page RL, II, Munger MA, Nathisuwan S, Chaiyakunapruk N*. JACCP Journal of the American College of Clinical Pharmacy 2021; 4(7): 871-882.
   
   

4. Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi-center, cross-sectional study

   Widjaja KK, Chulavatnatol S, Suansanae T, Wibowo YI, Sani AF, Islamiyah WR, Nathisuwan S*. Int J Clin Pharm 2021; 43(3): 666-672.
   
   

5. Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand

   Wattanaruengchai P, Nathisuwan S*, Rattanavipanon W, Chulavatnatol S, Kongwatcharapong J, Mitsuntisuk P, Chaiyasothi T, Kritsanapipat D, Phrommintikul A, Chaiyakunapruk N, Likittanasombat K, Lip GYH. British journal of clinical pharmacology 2021; 87(3): 1390-1400.
   
   

6. Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT 2 R 2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): A study protocol

   Phrommintikul A, Nathisuwan S, Gunaparn S, Krittayaphong R, Wongcharoen W, Sehmi S, Mehta S, Winkles N, Brocklehurst P, Mathers J, Jowett S, Jolly K, Lane D, Thomas GN, Lip GYH*. BMJ Open 2021; 11(10): e051987.
   
   

7. Real-world comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in a developing country

   Mitsuntisuk P, Nathisuwan S*, Junpanichjaroen A, Wongcharoen W, Phrommintikul A, Wattanaruengchai P, Rattanavipanon W, Chulavatnatol S, Chaiyakunapruk N, Likittanasombat K, Lip GYH. Clinical Pharmacology and Therapeutics 2021; 109(5): 1282-1292.
   
   

8. Real-world experience of angiotensin receptor/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis

   Rattanavipanon W, Sotananusak T, Yamaae F, Chandrsawang A, Kaewkan P, Nathisuwan S, Yingchoncharoen T*. BMC Cardiovascular Disorders 2021; 21(1): 324.
   
   

2020

1. Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis.

   Ng SS, Lai NM, Nathisuwan S, Jahan NK, Dilokthornsakul P, Kongpakwattana K, Hollingworth W, Chaiyakunapruk N*. Scientific reports 2020; 10(1): 662.
   
   

2. Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation

   Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U*. Heart lung and circulation 2020; 29(3): 390-400.
   
   

3. Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand

   Ng SS, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N*. Thrombosis research 2020; 185: 63-71.
   
   

4. Knowledge of stroke and medication adherence among patients with recurrent stroke or transient ischemic attack in Indonesia: a multi‑center, cross‑sectional study

   Widjaja KK, Chulavatnatol S, Suansanae T, Wibowo YI, Sani AF, Islamiyah WR, Nathisuwan S International Journal of Clincal Pharmacy 2020 Oct 29. doi: 10.1007/s11096-020-01178-y
   
   

5. Prescriber compliance to direct oral anticoagulant labels and impact on outcomes in Thailand

   Wattanaruengchai P, Nathisuwan S, Rattanavipanon W, Chulavatnatol S, Kongwatcharapong J, Mitsuntisuk P, Chaiyasothi T, Kritsanapipat D, Phrommintikul A, Chaiyakunapruk N, Likittanasombat K, Lip GYH Br J Clin Pharmacol 2020 Aug 28. doi: 10.1111/bcp.14535
   
   

6. Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand

   Sukkha S, Rattanavipanon W, Chamroenwit B, Sanganurak M, Nathisuwan S, Chaikledkaew U, Kongwatcharapong J*. International journal of clinical pharmacy 2020; 42(2): 610-616.
   
   

7. Real-world comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in a developing country

   Mitsuntisuk P, Nathisuwan S, Junpanichjaroen A, Wongcharoen W, Phrommintikul A, Wattanaruengchai P, Rattanavipanon W, Chulavatnatol S, Chaiyakunapruk N, Likittanasombat K, Lip GYH Clin Pharmacol Ther 2020 Oct 28. doi: 10.1002/cpt.2090
   
   

8. Relationship of anemia and clinical outcome in heart failure patients with preserved versus reduced ejection fraction in a rural area of Thailand

   Chairat K, Rattanavipanon W, Tanyasaensook K, Chindavijak B, Chulavatnatol S, Nathisuwan S*. Int J cardiol heart vasc 2020; 30: 100597.
   
   

2019

1. Characteristic of drug-related problems and pharmacists’ interventions in a stroke unit in Thailand

   Semcharoen K, Supornpun S, Nathisuwan S, Kongwatcharapong J*. International Journal of Clinical Pharmacy -
   
   

2. Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand

   Kongpakwattana K, Ademi Z, Chaiyasothi T, Nathisuwan S*, Zomer E, Liew D, Chaiyakunapruk N. Pharmacoeconomics 2019; 37(10); 1277-1286.
   
   

3. Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation

   Dilokthornsakul P, Nathisuwan S, Krittayaphong R, Chutinet A, Permsuwan U*. Heart Lung and Circulation -
   
   

4. Effects of Non-statin Lipid-Modifying Agents on Cardiovascular Morbidity and Mortality Among Statin-Treated Patients: A Systematic Review and Network Meta-Analysis

   Chaiyasothi T, Nathisuwan S, Dilokthornsakul P, Vathesatogkit P, Thakkinstian A, Reid C, Wongcharoen W, Chaiyakunapruk N. FRONTIERS IN PHARMACOLOGY 2019;10:547
   
   

5. Efficacy and safety of celecoxib on the incidence of recurrent colorectal adenomas: A systematic review and meta-analysis

   Veettil SK, Nathisuwan S, Ching SM, Jinatongthai P, Lim KG, Kew ST, Chaiyakunapruk N. Cancer Management and Research 2019; 11: 561-571.
   
   

6. Incidence, risk factors, and outcomes of warfarin-associated major bleeding in Thai population

   Priksri W, Rattanavipanon W, Saejear W, Tanyasaensook K, Phrommintikul A, Chulavatnatol S, Nathisuwan S Pharmacoepidemiology and Drug Safety 2019;28:942-950
   
   

7. Relationship of medication adherence and quality of life among heart failure patients

   Silavanich V, Nathisuwan S, Phrommintikul A, Permsuwan U*. Heart and Lung 2019; 48(2): 105-110.
   
   

8. Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect

   Leong SL, Chaiyakunapruk N, Tassaneeyakul W, Arunmanakul P, Nathisuwan S*, Lee SWH. International Journal of Cardiology 2019; 280: 190-197.
   
   

2018

1. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from caucasian, asian, and mixed races in Thai population

   Chumnumwat S, Yi K, Lucksiri A, Nosoongnoen W, Chindavijak B, Chulavatnatol S, Sarapakdi A, Nathisuwan S*. Cardiovascular Therapeutics 2018; 36(2): e12315
   
   

2. Efficacy and safety of chemopreventive agents on colorectal cancer incidence and mortality: systematic review and network meta-analysis.

   Veettil SK, Jinatongthai P, Nathisuwan S, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Reid CM, Chaiyakunapruk N Clinical Epidemiology 2018; 10: 1433-1445
   
   

3. Interventions and strategies to Improve Oral anticoagulant use in patients with atrial fibrillation: a Systematic review of systematic Reviews

   Ng SS, Lai NM, Nathisuwan S, Chaiyakunapruk N.* Clinical Drug Investigation 2018; 38(7): 579-591
   
   

4. Relationship of medication adherence and quality of life among heart failure patients

   Silavanich V., Nathisuwan S., Phrommintikul A., Permsuwan U*. Heart and Lung 2018; (Article in Press)
   
   

2017

1. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis

   Jinatongthai P, Kongwatcharapong J, Foo CY, Phrommintikul A, Nathisuwan S, Thakkinstian A, Reid CM, Chaiyakunapruk N*. The Lancet 2017; 390(10096): 747-759.
   
   

2. Genotypic detection of the blaCTX-M-1 gene among extended-spectrum β-lactamase-producing Enterobacteriaceae

   Thuengern A, Nathisuwan S, Chomnawang MT, Wiwat C, Thirapanmethee K*. Journal of Global Antimicrobial Resistance 2017; 9: 87-93.
   
   

2016

1. Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials.

   Kongwatcharapong J, Dilokthornsakul P, Nathisuwan S, Phrommintikul A, Chaiyakunapruk N*. International Journal of Cardiology. 2016; 211: 88-95.
   
   

2015

1. Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand

   Permsuwan U*, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A. Heart Lung and Circulation 2015; 24(9): 860-868
   
   

2. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database

   Win TSZ, Chaiyakunapruk N, Suwankesawong W, Dilokthornsakul P, Nathisuwan S*. Asian pacific journal of allergy and immunology. 2015; 33(3): 227-235
   
   

2014

1. Loop-mediated isothermal amplification assay targeting the blaCTX-M9 gene for detection of extended spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

   Thirapanmethee K*, Pothisamutyothin K., Nathisuwan S, Chomnawang MT, Wiwat C. Microbiology and Immunology 2014; 58(12): 655-665
   
   

2. Use of the CRUSADE Bleeding Risk Score in the Prediction of Major Bleeding for Patients with Acute Coronary Syndrome Receiving Enoxaparin in Thailand

   Jinatongthai P, Khaisombut N, Likittanasombat K, Chaiyakunapruk N, Watcharathanakij S, Nathisuwan S*. Heart Lung and Circulation 2014; 23(11): 1051-1058
   
   

2013

1. Characteristics of Renin Angiotensin System Blockers-induced Angioedema in Thailand

   Win TSZ (Win, T. S. Z.), Nathisuwan S, Chaiyakunapruk N, Suwankesawong W, Tanyasaensook K, Dilokthornsakul P. International journal of clinical pharmacy. 2013; 35(6): 1292-1292
   
   

2. Characterization of statin-associated myopathy case reports in thailand using the health product vigilance center database

   Boonmuang P, Nathisuwan S*, Chaiyakunapruk N, Suwankesawong W, Pokhagul P, Teerawattanapong N, Supsongserm P. Drug Safety 2013; 36(9): 779-787
   
   

3. Cost-effectiveness of CYP2C9 and VKORC1 genetic testing to predict warfarin guided dose in Thai population

   Salek S, Dumrongprat K, Nathisuwan S. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2013; 35(5): 1005-1005.
   
   

4. Cost-Effectiveness of Pharmacist-Participated Warfarin Therapy Management in Thailand

   Saokaew S, Permsuwan U, Chaiyakunapruk N, Nathisuwan S, Sukonthasarn A, Jeanpeerapong N Thrombosis Research 2013; 132(4): 437-443
   
   

5. Erratum: Characterization of statin-associated myopathy case reports in Thailand using the health product vigilance center database (Drug Safety DOI: 10.1007/s40264-013-0055-5)

   Boonmuang P, Nathisuwan S*, Chaiyakunapruk N, Suwankesawong W, Pokhagul P, Teerawattanapong N, Supsongserm P. Drug Safety 2013; 36(7): 583-584
   
   

6. Risk factors Related to Rhabdomyolysis in Thai Statin Users: A Case-control Study

   Supsongserm P, Boonmuang P, Nathisuwan S, Chaiyakunapruk N, Tanyasaensook K* Mahidol University Journal of Pharmaceutical Sciences 2013; 40 (4), 1-7
   
   

2012

1. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand

   Saokaew S, Sapoo U, Nathisuwan S, Chaiyakunapruk N, International Journal of Clinical Pharmacy 2012; 34(1): 105-112
   
   

2. Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding

   Saokaew S, Khaisombat N, Chaiyakunapruk N*, Likittanasombat K, Nathisuwan S. Value in Health Regional Issues 2012; 1(1): 41-45
   
   

2011

1. Assessing evidence of interaction between smoking and warfarin: A systematic review and meta-analysis

   Nathisuwan S, Dilokthornsakul P, Chaiyakunapruk N*, Morarai T, Yodting T, Piriyachananusorn N. Chest 2011; 139(5): 1130-1139
   
   

2. การดูแลตนเองเกี่ยวกับการใช้ยาของผู้สูงอายุโรคปอดอุดกั้นเรื้อรัง

   พนิดา ไกรนรา, พรทิพย์ มาลาธรรม, สุรกิจ นาฑีสุวรรณ, ธีระศักดิ์ แก้วอมตะวงศ์ รามาธิบดีพยาบาลสาร 2011; 17(2): 287-304.
   
   

2010

1. Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel

   Siriswangvat S,Sansanayudh N, Nathisuwan S, Panomvana D*. Circ J 2010; 74(10): 2187-2192.
   
   

2. Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis

   Saokaew S, Permsuwan U, Chaiyakunapruk N*, Nathisuwan S, Sukonthasarn A. J Thromb Haemost 2010; 8(11): 2418-2427.
   
   

2007

1. Utilisation review of clopidogrel: Are they used under the FDA-approved indications?

   Niruntraporn S, Chaiyakunapruk N*, Nathisuwan S, Thamlikitkul V. Pharmacoepidemiology and Drug Safety. 2007; 16(9) Sep: 1031-1037.
   
   

2006

1. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis.

   Chaiyakunapruk N*, Kitikannakorn N, Nathisuwan S, Leeprakobboon K, Leelasettagool C. Am J Obstet Gynecol 2006 Jan; 194(1): 95-9.
   
   

2005

1. Prevention of adverse drug reactions in hospitalised patients by pharmacist participation at a large teaching hospital in Thailand.

   Tragulpiankit P, Pummangura C, Luscombe DK, Kaojarern S, Wananukul W, Montakantikul P, Nathisuwan S. Drug Safety 2005;28(10):931.
   
   

2003

1. Faculty turnover within academic pharmacy departments.

   Carter O, Nathisuwan S, Stoddard GJ, Munger MA. Ann Pharmacother 2003; 37: 197-201
   
   

2002

1. Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.

   Burgess DS, Nathisuwan S. Diagn Microbiol Infect Dis 2002; 44: 35-41
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ Assoc. Prof. Surakit Nathisuwan ได้แก่ สุรกิจ นาฑีสุวรรณ ; Nathisuwan S ;